KALYN SEALE: Open Payments
NPI 1790451979 · HERNANDO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$879 in 48 payments from 12 companies in 2025. Trend: 2023 $1,265 · 2024 $1,114 · 2025 $879
Food & beverage: $879
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $242 |
| ABBVIE INC. | 13 | $196 |
| Novo Nordisk Inc | 7 | $127 |
| Lilly USA, LLC | 4 | $76 |
| PFIZER INC. | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| IBSA Pharma Inc. | 2 | $34 |
| Antares Pharma, Inc. | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $20 |
Products named: UBRELVY, AIRSUPRA, FARXIGA, Ozempic, JARDIANCE, Kerendia, GEMTESA, Tirosint.
Industry payments across MS — which companies pay providers there.
